Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zampieri

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 29, 2022
Association between Type of Fluid Received Prior to Enrollment, Type of Admission, and Effect of Balanced Crystalloid in Critically Ill Adults: A Secondary Exploratory Analysis of the BaSICS Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
The American Journal of Cardiology|December 17, 2023
Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical TrialsRemo H M Furtado, Pedro G M Barros E Silva, Henrique A R Fonseca, et al.
Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.
JAMA|June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical TrialCaio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
Critical Care Medicine|August 4, 2025
The Association of ICU Acuity and Organizational Factors With Outcomes of Low-Risk PatientsEmmanuel S Salgueiro, Pedro Kurtz, Lunna P Borges, et al.
JAMA|September 21, 2021
Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
Lancet (London, England)|September 8, 2020
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trialRemo H M Furtado, Otavio Berwanger, Henrique A Fonseca, et al.
JAMA|August 10, 2021
Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
JAMA|September 3, 2020
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialBruno M Tomazini, Israel S Maia, Alexandre B Cavalcanti, et al.
BMJ (Clinical Research Ed.)|January 21, 2021
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trialViviane C Veiga, João A G G Prats, Danielle L C Farias, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
American Journal of Respiratory and Critical Care Medicine|March 29, 2022
Association between Type of Fluid Received Prior to Enrollment, Type of Admission, and Effect of Balanced Crystalloid in Critically Ill Adults: A Secondary Exploratory Analysis of the BaSICS Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
The American Journal of Cardiology|December 17, 2023
Cardiovascular Safety of Azithromycin in Patients Hospitalized With COVID-19: A Prespecified Pooled Analysis of the COALITION I and COALITION II Randomized Clinical TrialsRemo H M Furtado, Pedro G M Barros E Silva, Henrique A R Fonseca, et al.
Journal of Critical Care|August 3, 2024
Antisense therapy to block the Kallikrein-kinin pathway in COVID-19: The ASKCOV randomized controlled trialFernando G Zampieri, Glauco Adrieno Westphal, Maria Adelaide Dos Santos, et al.
JAMA|June 14, 2024
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical TrialCaio A M Tavares, Luciano C P Azevedo, Álvaro Rea-Neto, et al.
Critical Care Medicine|August 4, 2025
The Association of ICU Acuity and Organizational Factors With Outcomes of Low-Risk PatientsEmmanuel S Salgueiro, Pedro Kurtz, Lunna P Borges, et al.
JAMA|September 21, 2021
Effect of Slower vs Faster Intravenous Fluid Bolus Rates on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
Lancet (London, England)|September 8, 2020
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trialRemo H M Furtado, Otavio Berwanger, Henrique A Fonseca, et al.
JAMA|August 10, 2021
Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical TrialFernando G Zampieri, Flávia R Machado, Rodrigo S Biondi, et al.
JAMA|September 3, 2020
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical TrialBruno M Tomazini, Israel S Maia, Alexandre B Cavalcanti, et al.
BMJ (Clinical Research Ed.)|January 21, 2021
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trialViviane C Veiga, João A G G Prats, Danielle L C Farias, et al.
Pageof 14